Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nuvation Bio Inc shares valued at $50,024 were sold by Liu Dongfang on May 02 ’25. At $2.50 per share, Liu Dongfang sold 20,000 shares. The insider’s holdings dropped to 12,000 shares worth approximately $26400.000000000004 following the completion of this transaction.
Also, DONGFANG LIU purchased 20,000 shares, netting a total of over 45,400 in proceeds.
Before that, Hung David had added 300,000 shares to its account. In a trade valued at $487,500, the PRESIDENT AND CEO bought Nuvation Bio Inc shares for $1.62 each. Upon closing the transaction, the insider’s holdings increased to 300,000 shares, worth approximately $129.32 million.
As published in their initiating research note from Citizens JMP on April 23, 2025, Nuvation Bio Inc [NUVB] has been a Mkt outperform and the price target has been revised to $6. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late March. As of March 26, 2024, BTIG Research has increased its “Neutral” rating to a “Buy” for NUVB. Earlier on January 06, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for NUVB stock which previously was a “a Buy”.
Analyzing NUVB Stock Performance
During the last five days, there has been a surge of approximately 1.38%. Over the course of the year, Nuvation Bio Inc shares have dropped approximately -17.29%. Shares of the company reached a 52-week high of $3.45 on 01/07/25 and a 52-week low of $1.54 on 04/07/25.
Support And Resistance Levels for Nuvation Bio Inc (NUVB)
According to the 24-hour chart, there is a support level at 2.11, which, if violated, would cause prices to drop to 2.01. In the upper region, resistance lies at 2.32. The next price resistance is at 2.44. RSI (Relative Strength Index) is 52.06 on the 14-day chart, showing neutral technical sentiment.
